Biodegradable and thermoresponsive micelles of triblock copolymers based on 2-(N,N-dimethylamino)ethyl methacrylate and ε-caprolactone for controlled drug delivery
JavaScript is disabled for your browser. Some features of this site may not work without it.
Biodegradable and thermoresponsive micelles of triblock copolymers based on 2-(N,N-dimethylamino)ethyl methacrylate and ε-caprolactone for controlled drug delivery
Sponsor:
The authors thank the Plan Nacional I + D + I (Ministerio de Educación y Ciencia) for financial support (MAT2006-05979) as well as the Comunidad Autónoma de Madrid
for the funding through I + D Program (S0505/MAT-0227).
Project:
Gobierno de España. MAT2006-05979 Comunidad de Madrid. S0505/MAT-0227
Keywords:
Block copolymer
,
Micelles
,
Temperature sensitivity
,
Controllable drug release
,
Chemotherapy
Amphiphilic triblock copolymers, poly(2-(N,N-dimethylamino)ethyl methacrylate)x-block-poly(caprolactone)-block-poly(2-(N,N-dimethylamino)ethyl methacrylate)x, PDMAEMACo, were synthesized. Polymerization and structural features of the polymers were analyzed by Amphiphilic triblock copolymers, poly(2-(N,N-dimethylamino)ethyl methacrylate)x-block-poly(caprolactone)-block-poly(2-(N,N-dimethylamino)ethyl methacrylate)x, PDMAEMACo, were synthesized. Polymerization and structural features of the polymers were analyzed by different physicochemical techniques (GPC, ¹H NMR and FTIR). Formation of hydrophobic domains as cores of the micelles was studied by ¹H NMR and further confirmed by fluorescence. Dynamic light scattering measurements showed a monodispersed size distribution only for the copolymer with the lowest degree of polymerization, while increasing the length of PDMAEMA blocks leads to a bimodal size distribution. The micelles showed reversible dispersion/aggregation in response to temperature cycles through an outer polymer shell lower critical solution temperature (LCST) for PDMAEMA at temperatures between 54 and 87 °C. The triblock copolymer micelles were loaded with the sparingly water-soluble anticancer drug, chlorambucil, by a dialysis procedure. The drug release profile monitored by fluorescence showed that the release of chlorambucil from PDMAEMA nanoparticles is controlled by a combined degradation–diffusion mechanism.[+][-]